EPAZ yields 7692.31% · PFE yields 6.13%● Live data
📍 EPAZ pulled ahead of the other in Year 1
Combined, EPAZ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EPAZ + PFE for your $10,000?
Epazz, Inc., together with its subsidiaries, designs and sells various software programs to business enterprises, hospitals, and government and post-secondary institutions in the United States. It offers EPAZZ BoxesOS v3.0, a Web portal infrastructure operating system that integrates with each organization's back-end systems and provides a customizable personal information system for various stakeholders, including students, faculty, alumni, employees, and clients. The company also provides AutoHire software, an interactive question, and online screening and ranking system; and Desk Flex software that allow businesses make use of office space restrictions by enabling employees to instantly access their workstation tools from various areas in and outside of the office. In addition, it offers Agent Power software, which provides information and tools for call centers to help enhance their workforce management; Integrated Plant Management Control software, a software system design for water and wastewater facility management; and CHMCi, an enterprise solution that includes tools to provide, manage, bill, and track behavioral healthcare and social services. Further, the company provides K9 Bytes, a point of sale (POS) software for pet care applications, such as pet boarding; daycare; grooming; training; and other pet care services, including dog walking and pet sitting. Its K9 Bytes products include scheduling, billing, retail inventory, and general POS capabilities comprising credit and debit card processing, collar printers, digital signature tablets, and biometric/fingerprint identification hardware. Epazz, Inc. was founded in 2000 and is headquartered in Chicago, Illinois.
Full EPAZ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.